Clinical review demonstrates sequential triplet regimens and targeted immunotherapies for relapsed multiple myeloma, highlighting expanding treatment lines.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
S. Vincent Rajkumar (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: